Compile Data Set for Download or QSAR
Report error Found 181 Enz. Inhib. hit(s) with all data for entry = 7355
TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791131BDBM791131(ethyl (Z)-2-cyano-3-hydroxy-3-(4-hydroxy-3-methoxy...)
Affinity DataIC50: 50nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791092BDBM791092((Z)-3-(3-chloro-5-cyano-4- hydroxyphenyl)-2-cyano-...)
Affinity DataIC50: 60nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791104BDBM791104((Z)-2-cyano-3-(3,5-dichloro-4- hydroxyphenyl)-N-(2...)
Affinity DataIC50: 60nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791105BDBM791105((Z)-2-cyano-N-(5-cyano-2-fluorobenzyl)- 3-(3,5-dic...)
Affinity DataIC50: 70nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791125BDBM791125((Z)-N-(2-(2-chlorophenoxy)ethyl)-2- cyano-3-(3-cya...)
Affinity DataIC50: 80nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791097BDBM791097((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-(3-cyan...)
Affinity DataIC50: 80nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791054BDBM791054((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N-((4...)
Affinity DataIC50: 80nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791131BDBM791131(ethyl (Z)-2-cyano-3-hydroxy-3-(4-hydroxy-3-methoxy...)
Affinity DataIC50: 80nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791126BDBM791126((Z)-2-cyano-3-(3-cyano-5-fluoro-4- hydroxyphenyl)-...)
Affinity DataIC50: 90nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791085BDBM791085((Z)-2-cyano-3-(3-cyano-5-fluoro-4- hydroxyphenyl)-...)
Affinity DataIC50: 90nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791090BDBM791090((Z)-2-cyano-3-(3,5-dicyano-4- hydroxyphenyl)-N-(2-...)
Affinity DataIC50: 90nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791141BDBM791141((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-(3-(dif...)
Affinity DataIC50: 90nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791051BDBM791051((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-3-hyd...)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791086BDBM791086((Z)-2-cyano-3-(3-cyano-4- hydroxyphenyl)-N-(2-fluo...)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791094BDBM791094((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-(3,5-di...)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791106BDBM791106((Z)-2-cyano-3-(3-cyano-4- hydroxyphenyl)-N-(2-fluo...)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791060BDBM791060(((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N-(2...)
Affinity DataIC50: 110nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791057BDBM791057((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N-(2-...)
Affinity DataIC50: 120nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791056BDBM791056((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-3-hyd...)
Affinity DataIC50: 120nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791066BDBM791066((Z)-2-cyano-N-(2-fluoro-5- methoxybenzyl)-3-hydrox...)
Affinity DataIC50: 120nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791134BDBM791134((Z)-2-(cyclopropanecarbonyl)-3-hydroxy-3-(4-hydrox...)
Affinity DataIC50: 120nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791050BDBM791050((Z)-N-(2-chlorobenzyl)-2-cyano-3- (3,4-dihydroxy-5...)
Affinity DataIC50: 130nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791099BDBM791099((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-(3-cyan...)
Affinity DataIC50: 130nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791095BDBM791095((Z)-N-(5-chloro-2-fluorobenzyl)-3-(3- chloro-5-flu...)
Affinity DataIC50: 130nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791055BDBM791055((Z)-2-cyano-N-(2-fluoro-5- (pyrimidin-4-yl)benzyl)...)
Affinity DataIC50: 140nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791091BDBM791091((Z)-2-cyano-3-(3-cyano-4-hydroxy-5- methylphenyl)-...)
Affinity DataIC50: 140nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791113BDBM791113((Z)-2-cyano-N-(3-(2- cyanophenyl)propyl)-3-(3,4- d...)
Affinity DataIC50: 150nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791139BDBM791139((Z)-3-(5-chloro-2-fluoro-4- hydroxyphenyl)-N-(5-ch...)
Affinity DataIC50: 150nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791058BDBM791058((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N-(2-...)
Affinity DataIC50: 150nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791121BDBM791121((Z)-3-(3-chloro-4-hydroxy- 5-nitrophenyl)-2-cyano-...)
Affinity DataIC50: 150nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791134BDBM791134((Z)-2-(cyclopropanecarbonyl)-3-hydroxy-3-(4-hydrox...)
Affinity DataIC50: 150nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791007BDBM791007((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-3-hyd...)
Affinity DataIC50: 150nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791093BDBM791093((Z)-2-cyano-3-(3,5-dichloro-4- hydroxyphenyl)-N-(2...)
Affinity DataIC50: 150nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791065BDBM791065((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-hydroxy...)
Affinity DataIC50: 160nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791063BDBM791063((Z)-2-cyano-N-(2-fluoro-5- methylbenzyl)-3-hydroxy...)
Affinity DataIC50: 160nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791052BDBM791052((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N-(2-...)
Affinity DataIC50: 160nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791089BDBM791089((Z)-2-cyano-3-(3-cyano-4-hydroxy-5- methoxyphenyl)...)
Affinity DataIC50: 160nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791049BDBM791049((Z)-2-cyano-N-(2-fluorobenzyl)-3- hydroxy-3-(4-hyd...)
Affinity DataIC50: 170nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791108BDBM791108((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-3-hyd...)
Affinity DataIC50: 170nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791053BDBM791053((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N-(2-...)
Affinity DataIC50: 170nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791112BDBM791112((Z)-N-(3-(2-chlorophenyl)propyl)- 2-cyano-3-(3,4-d...)
Affinity DataIC50: 200nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791098BDBM791098((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-(3-cyan...)
Affinity DataIC50: 200nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791123BDBM791123((Z)-3-(3-chloro-5-cyano-4- hydroxyphenyl)-2-cyano-...)
Affinity DataIC50: 210nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791096BDBM791096((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-(3,5-di...)
Affinity DataIC50: 210nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791109BDBM791109((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-3-hyd...)
Affinity DataIC50: 210nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

TargetCatechol O-methyltransferase(Human)
Rpxds

US Patent
LigandChemical structure of BindingDB Monomer ID 791115BDBM791115(US20260035341, Example 5)
Affinity DataIC50: 210nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791144BDBM791144((Z)-N-(5-bromo-2-fluorobenzyl)-2- cyano-3-hydroxy-...)
Affinity DataIC50: 220nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791100BDBM791100((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-(3-cyan...)
Affinity DataIC50: 230nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791102BDBM791102((Z)-N-(5-chloro-2-fluorobenzyl)-2-cyano- 3-hydroxy...)
Affinity DataIC50: 250nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

LigandChemical structure of BindingDB Monomer ID 791122BDBM791122((Z)-2-cyano-3-(3-cyano-4- hydroxyphenyl)-3-hydroxy...)
Affinity DataIC50: 250nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent

Displayed 1 to 50 (of 181 total ) | Next | Last >>
Jump to: